Show simple item record

FieldValueLanguage
dc.contributor.authorHall, Andrew J.
dc.contributor.authorRobertson, Amy G.
dc.contributor.authorHill, Leila R.
dc.contributor.authorRendina, Louis M.
dc.date.accessioned2021-03-30T05:03:35Z
dc.date.available2021-03-30T05:03:35Z
dc.date.issued2021en_AU
dc.identifier.urihttps://hdl.handle.net/2123/24767
dc.description.abstractThe synthesis of a new series of Gd(III)-arylphosphonium complexes is described and the solution stability of selected compounds is reported. Their lipophilicity and uptake in human glial (SVG p12) and human glioblastoma multiforme (T98G) cell lines are presented. The in vitro cytotoxicity of all complexes was determined to be low at therapeutically-relevant concentrations. Selected Gd(III) complexes are potential candidates for further investigation as theranostic agents.en_AU
dc.language.isoenen_AU
dc.publisherNatureen_AU
dc.relation.ispartofScientifc Reportsen_AU
dc.rightsCopyright All Rights Reserveden_AU
dc.subjectgadoliniumen_AU
dc.subjectcell uptakeen_AU
dc.subjectdelocalised lipophilic cationen_AU
dc.subjectmitochondriaen_AU
dc.subjectneutron capture therapyen_AU
dc.subjectphoton activation therapyen_AU
dc.subjectDOTAen_AU
dc.titleSynthesis and tumour cell uptake studies of gadolinium(III)–phosphonium complexesen_AU
dc.typeArticleen_AU
dc.subject.asrc03 Chemical Sciencesen_AU
dc.subject.asrc0302 Inorganic Chemistryen_AU
dc.subject.asrc0304 Medicinal and Biomolecular Chemistryen_AU
dc.identifier.doi10.1038/s41598-020-79893-9
dc.relation.arcDP190103461
usyd.facultySeS faculties schools::Faculty of Science::School of Chemistryen_AU
usyd.facultySydney Nanoen_AU
usyd.citation.volume11en_AU
usyd.citation.issue1en_AU
usyd.citation.spage598en_AU
workflow.metadata.onlyNoen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.